Alzheimer's disease
GAP Foundation Launches Second Study on Alzheimer's Blood Biomarkers
In Bio-Hermes-002, the nonprofit is hoping to evaluate the ability of individual or a combination of biomarkers to predict amyloid and tau aggregation.
Sunbird Bio Nabs $14M in Financing
The firm said that it will use the investments to support the development of its blood-based tests to aid the diagnosis and treatment of neurological disorders.
The field's rapid advances make securing reimbursement an important area of focus, researchers in a recent commentary argued.
Revvity Gets CE Mark for PCR Test Used to Guide Alzheimer's Therapy
Revvity's Euroimmun subsidiary has launched the EuroRealTime APOE assay in Europe for the detection and differentiation of common forms of the APOE gene.
The company aims to streamline its own lab operations while also enabling distribution of its Alzheimer's tests to outside labs both in the US and abroad.
Aug 7, 2024
Aug 1, 2024
Jul 30, 2024